Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedinotecMDNC 24 EV-to-FCF is 39.23 as of Sep. 03, 2026, which is 48% below its 10-year median of 74.82. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 1 warning sign investors should review.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medinotec's Enterprise Value is $56.88 Mil.
Medinotec's Free Cash Flow for the trailing twelve months (TTM) ended in May. 2026 was $1.45 Mil. Therefore, Medinotec's EV-to-FCF for today is 39.23.
The historical rank and industry rank for Medinotec's EV-to-FCF or its related term are showing as below:
MDNC'
s EV-to-FCF Range Over the Past 10 Years
Min: -280.53 Med: 74.82 Max: 4438.08
Current: 39.23
During the past 5 years, the highest EV-to-FCF of Medinotec was 4438.08. The lowest was -280.53. And the median was 74.82.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medinotec's share price for today is $5.00.
Medinotec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.080.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Medinotec EV-to-FCF Related Terms
Medinotec EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Medinotec's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medinotec's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinotec EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medinotec's EV-to-FCF falls into.
Medinotec's current Enterprise Value is $56.88 Mil.
Medinotec's Free Cash Flow for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.45 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinotec (MDNC) has a EV-to-FCF of 39.23 as of Sep. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medinotec and its competitors. This is 48% below median its historical median of 74.82.
Is Medinotec's EV-to-FCF too high?
Medinotec's current EV-to-FCF of 39.23 is 48% below median its 10-year median of 74.82. The Medical Devices & Instruments industry median EV-to-FCF is 24.28. Medinotec's value of 39.23 is 61.6% above this industry median. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's EV-to-FCF compare to NVNO and APYX?
Medinotec's EV-to-FCF of 39.23 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-FCF is 24.28. Medinotec's value of 39.23 is 61.6% above this benchmark. While the company's 10-year median is 74.82 vs. the industry median of 24.28, Medinotec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.28, based on 408 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinotec's current EV-to-FCF of 39.23 is 61.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current EV-to-FCF is 39.23, which is 48% below median its own 10-year median of 74.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current EV-to-FCF of 39.23. The current EV-to-FCF is 39.23, which is 48% below median its 10-year median of 74.82 and 61.6% above the Medical Devices & Instruments industry median of 24.28. Medinotec's overall GF Score™ is 24/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medinotec (MDNC), the current EV-to-FCF is 39.23 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score
Get the complete analysis for MDNC
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDNC has been successfully added to your 
